| Literature DB >> 35768097 |
Agnes S K Wong1, Samantha Burns2, Earl Woodruff2.
Abstract
INTRODUCTION: Stress is not experienced the same by everyone. Some individuals, such as individuals with autism spectrum disorder (ASD), are at risk of heightened sensitivity to stress responses. ASD is a neurodevelopmental disorder commonly characterised by deficits in social communication and social interaction. Among different stressor stimuli, social stressors are particularly worth our attention due to the social and communication challenges inherent in ASD. This study aims to systematically evaluate different social stressor stimuli in eliciting physiological reactivity in ASD, focusing on the children and adolescent population. METHODS AND ANALYSIS: We designed a study protocol for this study and submitted it to PROSPERO for systematic review registration. Any studies with children and adolescents with ASD between the ages of 0 and 18 in clinical and community settings will be included. All types of social stressor interventions will be included. The outcome of interest will include studies with physiological activity of the participants being measured, for example, measures related to autonomic functioning, electrodermal functioning and cortisol level. The primary literature sources will be across four electronic databases: MEDLINE, Embase, PsycInfo and CINAHL in August 2021. The second source of literature will be across grey literature, including ProQuest Dissertations & Theses Global and across clinical trial registries in August 2021. Hand searching of references will be performed on the reference lists of all included studies. Two volunteers pursuing postgraduate-level studies will independently search and screen potential studies for eligibility. Finally, all references considered by hand searching will be reviewed by two researchers. The methodological quality of the research will be assessed by adopting the quality assessment used by a previous study. The assessment consists of four primary categories: descriptive validity, internal validity, external validity and statistical conclusion validity. ETHICS AND DISSEMINATION: No ethical approval is required for this study. Results will be disseminated through conferences and publications in relevant peer-reviewed journals. PROSPERO REGISTRATION NUMBER: CRD42021244039. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: Child & adolescent psychiatry; MENTAL HEALTH; Physiology
Mesh:
Year: 2022 PMID: 35768097 PMCID: PMC9244685 DOI: 10.1136/bmjopen-2021-060048
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Inclusion and exclusion criteria
| Inclusion | Exclusion |
| Any studies that include participants with the entire sample with ages between 0 year and 18 years of age, inclusive. | The publication was not in English. |
| At least one participant diagnosed with ASD with the method of diagnosis said explicitly. | Only physiological activity at baseline was measured. |
| Participants were exposed to at least one stressor stimulus condition different from the baseline. | The physiological measures were collected during challenging behaviours. |
| The physiological activity of the participants was measured, for example, measures related to autonomic functioning (eg, HR, HRV and RSA), electrodermal functioning (eg, EDA and SCL) or cortisol level. | The physiological measures were used for examining the treatment effects. |
| | The participants with different diagnoses were grouped together for analysis. |
| | Physiological responses to more than one stimulus were grouped together for analysis. |
ASD, autism spectrum disorder; EDA, electrodermal activity; HR, heart rate; HRV, heart rate variability; RSA, respiratory sinus arrhythmia; SCL, skin conductance level.